AT328627B - Verfahren zur herstellung von neuen 2- (thienylmethyl)-5,9beta-dialkyl-6,7-benzomorphanen - Google Patents

Verfahren zur herstellung von neuen 2- (thienylmethyl)-5,9beta-dialkyl-6,7-benzomorphanen

Info

Publication number
AT328627B
AT328627B AT489474*7A AT489474A AT328627B AT 328627 B AT328627 B AT 328627B AT 489474 A AT489474 A AT 489474A AT 328627 B AT328627 B AT 328627B
Authority
AT
Austria
Prior art keywords
benzomorphanes
9beta
thienylmethyl
dialkyl
preparation
Prior art date
Application number
AT489474*7A
Other languages
German (de)
English (en)
Other versions
ATA489474A (de
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of ATA489474A publication Critical patent/ATA489474A/de
Application granted granted Critical
Publication of AT328627B publication Critical patent/AT328627B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
AT489474*7A 1972-06-19 1973-06-06 Verfahren zur herstellung von neuen 2- (thienylmethyl)-5,9beta-dialkyl-6,7-benzomorphanen AT328627B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2229695A DE2229695A1 (de) 1972-06-19 1972-06-19 2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
ATA489474A ATA489474A (de) 1975-06-15
AT328627B true AT328627B (de) 1976-03-25

Family

ID=5848060

Family Applications (6)

Application Number Title Priority Date Filing Date
AT489474*7A AT328627B (de) 1972-06-19 1973-06-06 Verfahren zur herstellung von neuen 2- (thienylmethyl)-5,9beta-dialkyl-6,7-benzomorphanen
AT490074*7A AT328629B (de) 1972-06-19 1973-06-06 Verfahren zur herstellung von neuen 2- (furylmethyl) -5,9beta-dialkyl-6,7-benzomorphanen
AT494373A AT325218B (de) 1972-06-19 1973-06-06 Verfahren zur herstellung von neuen 2-(heteroarylmethyl)-5,9beta-dialkyl-6,7-benzomorphanen
AT489874*7A AT329199B (de) 1972-06-19 1973-06-06 Verfahren zur herstellung von neuen 2-(heteroaryl-methyl)-5,9beta-dialkyl-6,7-benzomorphanen
AT489774*7A AT328628B (de) 1972-06-19 1973-06-06 Verfahren zur herstellung von neuen 2- (heteroarylmethyl) -5,9beta-dialkyl-6,7-benzomorphanen
AT489974*7A AT329200B (de) 1972-06-19 1973-06-06 Verfahren zur herstellung von neuen 2- (heteroaryl-methyl) -5,9beta-dialkyl -6,7-benzomorphanen

Family Applications After (5)

Application Number Title Priority Date Filing Date
AT490074*7A AT328629B (de) 1972-06-19 1973-06-06 Verfahren zur herstellung von neuen 2- (furylmethyl) -5,9beta-dialkyl-6,7-benzomorphanen
AT494373A AT325218B (de) 1972-06-19 1973-06-06 Verfahren zur herstellung von neuen 2-(heteroarylmethyl)-5,9beta-dialkyl-6,7-benzomorphanen
AT489874*7A AT329199B (de) 1972-06-19 1973-06-06 Verfahren zur herstellung von neuen 2-(heteroaryl-methyl)-5,9beta-dialkyl-6,7-benzomorphanen
AT489774*7A AT328628B (de) 1972-06-19 1973-06-06 Verfahren zur herstellung von neuen 2- (heteroarylmethyl) -5,9beta-dialkyl-6,7-benzomorphanen
AT489974*7A AT329200B (de) 1972-06-19 1973-06-06 Verfahren zur herstellung von neuen 2- (heteroaryl-methyl) -5,9beta-dialkyl -6,7-benzomorphanen

Country Status (13)

Country Link
US (1) US3931194A (cg-RX-API-DMAC10.html)
JP (1) JPS5711908B2 (cg-RX-API-DMAC10.html)
AT (6) AT328627B (cg-RX-API-DMAC10.html)
BE (1) BE801079A (cg-RX-API-DMAC10.html)
CH (9) CH582698A5 (cg-RX-API-DMAC10.html)
DE (1) DE2229695A1 (cg-RX-API-DMAC10.html)
DK (1) DK136904C (cg-RX-API-DMAC10.html)
ES (8) ES416037A1 (cg-RX-API-DMAC10.html)
FR (1) FR2189056B1 (cg-RX-API-DMAC10.html)
GB (1) GB1433817A (cg-RX-API-DMAC10.html)
NL (1) NL7308483A (cg-RX-API-DMAC10.html)
NO (1) NO137694C (cg-RX-API-DMAC10.html)
SE (1) SE405121B (cg-RX-API-DMAC10.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2437610A1 (de) * 1974-08-05 1976-02-26 Boehringer Sohn Ingelheim Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung
GB1575009A (en) * 1976-06-21 1980-09-17 Acf Chemiefarma Nv 6,7-benzomorphan derivatives
JPS63177704A (ja) * 1987-01-16 1988-07-21 松山株式会社 農作業機連結装置
AR067673A1 (es) 2007-07-26 2009-10-21 Vitae Pharmaceuticals Inc Derivados de 1,3 oxazinan - 2 - ona como inhibidores ciclicos de la 11 beta -hidroxiesteroide deshidrogenasa 1. composiciones farmaceuticas.
AR069545A1 (es) * 2007-11-16 2010-02-03 Boehringer Ingelheim Pharma Derivados de aril y heteroarilcarbonilo de benzomorfanos y estructuras relacionadas, composiciones farmaceuticas que contienen dichos compuestos, obtencion de las mismas, su uso en el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa (hsd) 1 y
US8440658B2 (en) 2007-12-11 2013-05-14 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
JP5490020B2 (ja) 2008-01-24 2014-05-14 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状カルバゼート及びセミカルバジドインヒビター
EP2245014B1 (en) * 2008-02-12 2011-11-02 Boehringer Ingelheim International GmbH Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
WO2009102460A2 (en) 2008-02-15 2009-08-20 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2009134392A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2009134387A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
MX2010011935A (es) 2008-05-01 2011-05-19 Vitae Pharmaceuticals Inc Inhibidores ciclicos de 11 beta-hidroxiesteroide deshidrogenasa 1.
JP5711115B2 (ja) 2008-05-13 2015-04-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ベンゾモルファン及び関連骨格のアリサイクリックカルボン酸誘導体、そのような化合物を含有する医薬及びその使用
NZ590495A (en) 2008-07-25 2012-10-26 Vitae Pharmaceuticals Inc Dihydropyridin-phenyl-3-oxazinan-2-ones as inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2324017B1 (en) 2008-07-25 2014-12-31 Boehringer Ingelheim International GmbH INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
UA109255C2 (ru) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
EP2440537A1 (en) 2009-06-11 2012-04-18 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
TWI531571B (zh) * 2009-11-06 2016-05-01 維它藥物公司 六氫茚并吡啶及八氫苯并喹啉之芳基－及雜芳基羰基衍生物
WO2011159760A1 (en) 2010-06-16 2011-12-22 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基－及雜環芳基羰基衍生物
EP2744783A1 (en) 2011-08-17 2014-06-25 Boehringer Ingelheim International GmbH Indenopyridine derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE582575A (cg-RX-API-DMAC10.html) * 1958-09-22
FR1281227A (fr) * 1958-09-22 1962-01-12 Smith Kline French Lab Perfectionnements apportés aux procédés pour la préparation de dérivés d'aralcoylbenzomorphane
CS166803B2 (cg-RX-API-DMAC10.html) * 1971-02-08 1976-03-29 Boehringer Sohn Ingelheim
SE392895B (sv) * 1971-08-24 1977-04-25 Sumitomo Chemical Co Forfarande for framstellning av bensomorfanderivat och deras salter

Also Published As

Publication number Publication date
AT325218B (de) 1975-10-10
US3931194A (en) 1976-01-06
FR2189056A1 (cg-RX-API-DMAC10.html) 1974-01-25
NL7308483A (cg-RX-API-DMAC10.html) 1973-12-21
CH583229A5 (cg-RX-API-DMAC10.html) 1976-12-31
ATA489874A (de) 1975-07-15
AT329200B (de) 1976-04-26
ES416037A1 (es) 1976-02-16
CH583227A5 (cg-RX-API-DMAC10.html) 1976-12-31
CH589649A5 (cg-RX-API-DMAC10.html) 1977-07-15
AU5704673A (en) 1974-12-19
AT328629B (de) 1976-03-25
CH583230A5 (cg-RX-API-DMAC10.html) 1976-12-31
JPS5711908B2 (cg-RX-API-DMAC10.html) 1982-03-08
ES431513A1 (es) 1976-11-01
ES431510A1 (es) 1976-11-01
ES431516A1 (es) 1976-11-16
AT328628B (de) 1976-03-25
CH589648A5 (cg-RX-API-DMAC10.html) 1977-07-15
ES431514A1 (es) 1976-11-01
SE405121B (sv) 1978-11-20
ES431515A1 (es) 1976-11-01
ATA489474A (de) 1975-06-15
JPS4961170A (cg-RX-API-DMAC10.html) 1974-06-13
ES431511A1 (es) 1976-11-01
ES431512A1 (es) 1976-11-01
CH583228A5 (cg-RX-API-DMAC10.html) 1976-12-31
DE2229695A1 (de) 1974-01-31
CH583231A5 (cg-RX-API-DMAC10.html) 1976-12-31
GB1433817A (en) 1976-04-28
BE801079A (fr) 1973-12-18
NO137694C (no) 1978-04-05
FR2189056B1 (cg-RX-API-DMAC10.html) 1976-10-22
AT329199B (de) 1976-04-26
CH582698A5 (cg-RX-API-DMAC10.html) 1976-12-15
ATA489974A (de) 1975-07-15
CH582697A5 (cg-RX-API-DMAC10.html) 1976-12-15
NO137694B (no) 1977-12-27
ATA490074A (de) 1975-06-15
DK136904C (da) 1978-06-26
DK136904B (da) 1977-12-12
ATA489774A (de) 1975-06-15

Similar Documents

Publication Publication Date Title
AT340590B (de) Verfahren zur herstellung von neuen 7-acylaminocephalosporinderivaten
AT328627B (de) Verfahren zur herstellung von neuen 2- (thienylmethyl)-5,9beta-dialkyl-6,7-benzomorphanen
AT329076B (de) Verfahren zur herstellung von neuen 1-aminouracilen
AT331258B (de) Verfahren zur herstellung von neuen 1,2,3-oxathiazin-4-onen
AT324312B (de) Verfahren zur herstellung von neuen trifluormethylsalicylaniliden
AT315147B (de) Verfahren zur Herstellung von neuen N<1>-Alkoxyalkyliden-3,5-dinitro-sulfanilamiden
AT331998B (de) Verfahren zur herstellung von neuen 2-substituierten adenosin -3',5'- cyclomonophosphaten
AT324333B (de) Verfahren zur herstellung von neuen substituierten 5-chromanolen
AT330766B (de) Verfahren zur herstellung von neuen sulfamoylphenylimidazolidinonderivaten
AT323750B (de) Verfahren zur herstellung von neuen nitroimidazolyl-triazolc-pyridazinen
AT326115B (de) Verfahren zur herstellung von neuen 5-acylpyrrolderivaten
AT326837B (de) Verfahren zur herstellung von neuen 2,2'-anhydro-1-beta-d-arabinofuranosyl-5-fluorcytosin-hydrofluorid, -hydrochlorid oder -hydrobromid
AT332400B (de) Verfahren zur herstellung von neuen 4-phenylaminopyridinderivaten
AT316747B (de) Verfahren zur Herstellung von neuen Alkyl-7-deoxy-7-mercaptoalkylthio-α-thiolincosaminiden
AT315166B (de) Verfahren zur Herstellung von neuen 2-Acyl-5-nitrothiazolen
ATA489674A (de) Verfahren zur herstellung von neuen 2- (heteroarylmethyl)-5,9beta-dialkyl-6,7-benzomorphanen
ATA489574A (de) Verfahren zur herstellung von neuen 2- (heteroaryl-methyl) -5,9beta-dialkyl -6,7- benzomorphanen
ATA429175A (de) Verfahren zur herstellung von neuen 2- (heteroaryl-methyl) -5,9beta-dialkyl -6,7- benzomorphanen
AT323714B (de) Verfahren zur herstellung von neuen 6,9-dioxo-8-hydroxy-2-suestituierten-bicyclo-(3,3,1)-non-7-en-3-olen
AT324347B (de) Verfahren zur herstellung von neuen substituierten azetidin-2-onen
CH549056A (de) Verfahren zur herstellung von neuen o-vinylphosphorsaeureesteramiden.
AT329059B (de) Verfahren zur herstellung von neuen tetrahydroisochinolindionderivaten
AT330182B (de) Verfahren zur herstellung von neuen tetrahydroisochinolindionderivaten
ATA226075A (de) Verfahren zur herstellung von neuen tetrahydroisochinolindionderivaten
ATA226175A (de) Verfahren zur herstellung von neuen tetrahydroisochinolindionderivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee